MFIII Dermacenta (vegetal placenta) with stem cell extraction methodology, a substitute to animal & human placenta

For more than 20 years, Swiss and European scientist researchers and biotechonologists has been researching and developing a new & equally effective substitute for Animal Placenta Extract in cell therapy form. In 2001, this unique creation was successfully tested and developed and further enhanced in 2003 in the form of oral supplements released by Laboratoires Dom AVMM, Switzerland (under Swiss Public Health Approval No: AN-03/20'004 in 2004 by the name of MFIII of Switzerland VP Softgel 1780mg.

Similarly to mammals, plants do have embryos. The Placenta of the plant origin is produced at the heart of their young buds. It nourishes the fruit of the plant during its growing stage.

Dermacenta (vegetal placenta or VP in short) scientific code 511573, offers the same effect of a stimulating action on increased cell renewal and is deemed as a scentific substitute for human or animal placenta extracts. It regenerates & invigorates the skin, stimulating cellular renewal, improves the oxygen supply in our cell and enhance the protein synthesis in our skin to maintain its youthfulness.

Extracted from cell culture of a special rare species of Non GMO (non genetically modified) plant, Dermacenta is rich in Amino Acid particularly Alanine and Proline. It is hydrolised by enzymes and biostimulins

In an internal physiological scientific study conducted on human volunteers, the cellular turn-over was measured by the DHA method: The disappearance of the skin artificial color allows us to measure the rate of exfoliation and corneocytes turn-over. After using the product, diluted at 50%, for 11 days the cellular turn-over has been increased by minimum 26%.